marketcaparena

BLSM

BlossomHill Therapeutics, Inc.

Company overview

Market capitalization
$678.29M
Employees
—
Latest publication
2026-09-29

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Research Development21,355,000USD
Total Operating Expenses24,670,000USD
Net Income-23,758,000USD
SourceDisclosurePreliminary

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Total Assets124,131,000USD
Cash And Equivalents95,376,000USD
Total Current Assets100,968,000USD
Other Current Assets5,592,000USD
Other Non Current Assets2,477,000USD
Total Liabilities42,088,000USD
Total Current Liabilities18,621,000USD
Other Current Liabilities809,000USD
Other Non Current Liabilities1,245,000USD
Total Stockholder Equity-174,780,000USD
Total Equity Including Noncontrolling Interest82,043,000USD
Property Plant Equipment Net20,686,000USD
Accounts Payable3,930,000USD
Common Stock1,000USD
Retained Earnings-179,795,000USD
SourceDisclosureDeterministicFinal

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation250,000USD
Stock Based Compensation900,000USD
Change To Liabilities1,243,000USD
Change In Working Capital-689,000USD
Operating Cash Flow-44,174,000USD
Capital Expenditures-13,000USD
Investing Cash Flow-13,000USD
Financing Cash Flow2,881,000USD
Change In Cash-41,306,000USD
End Cash Flow95,376,000USD
SourceDisclosureDeterministicFinal

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.